| | | | | | | | | For the years ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Revenues | | — | | — | | 1,598 | Less: | | | | | | | Cost of revenues (1) | | — | | — | | (455) | Sales and marketing expenses (1) | | (51) | | (1) | | (539) | General and administrative expenses (1) | | (575) | | (293) | | (1,438) | Research and development expenses (1) | | — | | — | | (492) | Share-based compensation reversal/(expenses) | | 972 | | — | | (14) | Interest expenses, net | | (631) | | (14) | | (52) | Other segment items (2) | | (5,421) | | (10) | | 650 | Net loss from continuing operations | | (5,706) | | (318) | | (742) |
(1) Exclusive of share-based compensation expenses. (2) Other segment items included loss from disposal of subsidiaries, other expense/(income) and income tax expense.
|